The termination of the resale registration will not affect the ability of investors who are non-US persons, as defined in Regulation S of the US Securities Act of 1933, as amended (the '1933 Act'), to continue to sell their Common Shares in 2023 or thereafter.
US persons who hold Common Shares will continue to be able to sell their shares after
US persons may also sell unregistered Common Shares via a private placement.
Trilogy advises US persons who may wish to sell Common Shares after
About
Trilogy formerly operated wireless and broadband telecommunications subsidiaries in
Trilogy's head office is located at
Cautionary Statements
This press release contains 'forward-looking information' within the meaning of applicable securities laws in
Forward-looking information and statements are provided for the purpose of assisting readers in understanding management's current expectations and plans relating to the future. Readers are cautioned that such information and statements may not be appropriate for other purposes. Forward-looking information and statements contained in this press release are based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information and statements, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct.
Numerous risks and uncertainties, some of which may be unknown, relating to Trilogy could cause actual events and results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking information and statements. Such risks and uncertainties include but are not limited to changes in the securities regulations of
Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information and statements in this press release, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information in this press release. Please see our continuous disclosure filings available under Trilogy's profile at www.sedar.com and at www.sec.gov for information on the risks and uncertainties associated with our business.
Readers should not place undue reliance on forward-looking information and statements, which speak only as of the date made. The forward-looking information and statements contained in this press release represent our expectations as of the date of this press release. We disclaim any intention or obligation or undertaking to update or revise any forward-looking information or statements whether as a result of new information, future events or otherwise, except as required under applicable securities laws.
Contact:
Investor
Vice President
Investor Relations & Corporate Development
T: 425-458-5900
E: Ann.Saxton@trilogy-international.com
Senior Vice President
Chief Financial Officer
T: 425-458-5900
E: Erik.Mickels@trilogy-international.com
(C) 2022 Electronic News Publishing, source